Original Research

Published on 30 Mar 2022

Integrated Multi-Omics Analysis Identified PTPRG and CHL1 as Key Regulators of Immunophenotypes in Clear Cell Renal Cell Carcinoma(ccRCC)

in Cancer Immunity and Immunotherapy

Xing Zeng
Le Li
Zhiquan Hu
Dan Peng

Frontiers in Oncology

doi 10.3389/fonc.2022.832027

3,497 views
9 citations

Original Research

Published on 24 Mar 2022

Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Microenvironment, Sensitizing to Immune Checkpoint Therapy

in Cancer Immunity and Immunotherapy

Caitlin M. Tilsed
Thomas H. Casey
Emma de Jong
Anthony Bosco
Rachael M. Zemek
Joanne Salmons
Graeme Wan
Michael J. Millward
Anna K. Nowak
Richard A. Lake

Frontiers in Oncology

doi 10.3389/fonc.2022.849793

3,776 views
9 citations

Original Research

Published on 24 Mar 2022

Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival

in Cancer Immunity and Immunotherapy

Stavroula A. Paschou
Michael Liontos
Evangelos Eleftherakis-Papaiakovou
Katerina Stefanaki
Christos Markellos
Konstantinos Koutsoukos
Flora Zagouri
Theodora Psaltopoulou
Meletios-Athanasios Dimopoulos

Frontiers in Oncology

doi 10.3389/fonc.2022.847917

2,222 views
15 citations

Mini Review

Published on 23 Mar 2022

Regulation of Intrinsic Functions of PD-L1 by Post-Translational Modification in Tumors

in Cancer Immunity and Immunotherapy

Naoe Taira Nihira
Yoshio Miki

Frontiers in Oncology

doi 10.3389/fonc.2022.825284

2,752 views
6 citations

Case Report

Published on 23 Mar 2022

Immunotherapy Combined With Chemotherapy for Postoperative Recurrent Penile Squamous Cell Carcinoma: A Case Report and Literature Review

in Cancer Immunity and Immunotherapy

Na Li
Tangpeng Xu
Zhen Zhou
Ping Li
Guohua Jia
Xiangpan Li

Frontiers in Oncology

doi 10.3389/fonc.2022.837547

2,620 views
5 citations

Original Research

Published on 22 Mar 2022

A Novel Sushi-IL15-PD1 CAR-NK92 Cell Line With Enhanced and PD-L1 Targeted Cytotoxicity Against Pancreatic Cancer Cells

in Cancer Immunity and Immunotherapy

Da-Lai Xu
Yuan-Qing He
Bin Xiao
Yuan Si
Jian Shi
Xue-Ang Liu
Lei Tian
Qian Ren
Ya-Song Wu
Yi Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.726985

4,451 views
6 citations

Review

Published on 22 Mar 2022

Special Chimeric Antigen Receptor (CAR) Modifications of T Cells: A Review

in Cancer Immunity and Immunotherapy

Lele Miao
Juan Zhang
Binjie Huang
Zhengchao Zhang
Song Wang
Futian Tang
Muzhou Teng
Yumin Li

Frontiers in Oncology

doi 10.3389/fonc.2022.832765

7,055 views
23 citations

Review

Published on 21 Mar 2022

Biological Functions and Molecular Mechanisms of MiR-608 in Cancer

in Cancer Immunity and Immunotherapy

Juan Lu
Danhua Zhu
Lanjuan Li

Frontiers in Oncology

doi 10.3389/fonc.2022.870983

1,909 views
4 citations

Original Research

Published on 18 Mar 2022

The Role of m5C-Related lncRNAs in Predicting Overall Prognosis and Regulating the Lower Grade Glioma Microenvironment

in Cancer Immunity and Immunotherapy

Hongshu Zhou
Ming Meng
Zeyu Wang
Hao Zhang
Liting Yang
Chuntao Li
Liyang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.814742

4,961 views
16 citations

Original Research

Published on 18 Mar 2022

Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors

in Cancer Immunity and Immunotherapy

David S. Hong
Marcus O. Butler
Russell K. Pachynski
Ryan Sullivan
Partow Kebriaei
Sarah Boross-Harmer
Armin Ghobadi
Matthew J. Frigault
Ecaterina E. Dumbrava
Amy Sauer

Frontiers in Oncology

doi 10.3389/fonc.2022.818679

5,739 views
9 citations

Original Research

Published on 18 Mar 2022

ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in Gliomas

in Cancer Immunity and Immunotherapy

Shuyu Li
Nan Zhang
Shiyang Liu
Hao Zhang
Jiajing Liu
Yiwei Qi
Qi Zhang
Xingrui Li

Frontiers in Oncology

doi 10.3389/fonc.2022.844144

5,196 views
29 citations

Review

Published on 17 Mar 2022

Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development Directions

in Cancer Immunity and Immunotherapy

Dankun Luo
Haiwei Wang
Qiang Wang
Wenping Liang
Bo Liu
Dongbo Xue
Yang Yang
Biao Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.839536

4,819 views
13 citations

Original Research

Published on 17 Mar 2022

Efficacy and Safety of Low-Dose Nab-Paclitaxel Plus Tislelizumab in Elderly Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Wenyu Zhu
Qian Geng
Haoliang Peng
Zhihui Jin
Dongqing Li
Xiaolin Pu
Ge Wang
Hua Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.802467

3,883 views
6 citations

Original Research

Published on 15 Mar 2022

Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data

in Cancer Immunity and Immunotherapy

Rosanna Ruggiero
Barbara Stelitano
Federica Fraenza
Gabriella di Mauro
Cristina Scavone
Liberata Sportiello
Concetta Rafaniello
Raffaella Di Napoli
Romano Danesi
Marzia Del Re

Frontiers in Oncology

doi 10.3389/fonc.2022.824511

5,734 views
11 citations

Original Research

Published on 15 Mar 2022

Real-World Data of Different Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer in China

in Cancer Immunity and Immunotherapy

Kang Miao
Xiaotong Zhang
Hanping Wang
Xiaoyan Si
Jun Ni
Wei Zhong
Jing Zhao
Yan Xu
Minjiang Chen
Ruili Pan

Frontiers in Oncology

doi 10.3389/fonc.2022.859938

4,878 views
13 citations

Mini Review

Published on 15 Mar 2022

An Update on the Immunotherapy for Oropharyngeal Squamous Cell Carcinoma

in Cancer Immunity and Immunotherapy

Yaxuan Huang
Yunyun Lan
Zhe Zhang
Xue Xiao
Tingting Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.800315

9,174 views
13 citations

Navigation group

Articles

Integrated Multi-Omics Analysis Identified PTPRG and CHL1 as Key Regulators of Immunophenotypes in Clear Cell Renal Cell Carcinoma(ccRCC)

Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Microenvironment, Sensitizing to Immune Checkpoint Therapy

Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival

Regulation of Intrinsic Functions of PD-L1 by Post-Translational Modification in Tumors

Immunotherapy Combined With Chemotherapy for Postoperative Recurrent Penile Squamous Cell Carcinoma: A Case Report and Literature Review

A Novel Sushi-IL15-PD1 CAR-NK92 Cell Line With Enhanced and PD-L1 Targeted Cytotoxicity Against Pancreatic Cancer Cells

Special Chimeric Antigen Receptor (CAR) Modifications of T Cells: A Review

Biological Functions and Molecular Mechanisms of MiR-608 in Cancer

The Role of m5C-Related lncRNAs in Predicting Overall Prognosis and Regulating the Lower Grade Glioma Microenvironment

Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors

ITGA5 Is a Novel Oncogenic Biomarker and Correlates With Tumor Immune Microenvironment in Gliomas

Senecavirus A as an Oncolytic Virus: Prospects, Challenges and Development Directions

Efficacy and Safety of Low-Dose Nab-Paclitaxel Plus Tislelizumab in Elderly Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer

Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data

Real-World Data of Different Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer in China

An Update on the Immunotherapy for Oropharyngeal Squamous Cell Carcinoma